Partnerships for Rapid Diagnostics and Phenotypic Antibacterial Susceptibility Testing for Bacteremia or Hospital Acquired Pneumonia (R01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to support research projects focused on development and/or production of medical diagnostics that permit rapid differential species identification, and corresponding phenotypic antibacterial susceptibility profiles for bacteremia or hospital acquired pneumonia. The primary goal of such diagnostics is to facilitate antibacterial stewardship, thereby reducing selective pressure and improving patient outcomes.


  • Letter of Intent Due Date(s): 30 days prior to the application due date

  • Application Due Date: June 1, 2022

RFA-AI-22-010 Expiration Date June 2, 2022

Agency Website

Amount Description

Recommended budgets for direct costs of up to $500,000 per year may be requested. Applicants may also request up to an additional $150,000 in the first year of the award for major, essential equipment to ensure that research objectives can be met, totaling $650,000 direct costs for Year 1 only.

Funding Type





Medical - Basic Science
Medical - Clinical Science

External Deadline

June 1, 2022